bpc-157 human clinical trial safety and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC-157: Experimental Peptide Creates Risk
Description
J.ScottM

Remains on Category 2 with no current PCAC referral

other compounds may ultimately prove safe and useful for patient care, while others are just biologically implausible

it promotes vascular smooth muscle cell proliferation and inflammation in hypertension and is differentially expressed across patient subgroups

Without the full sequence, its impossible to reproduce the original work, a crucial form of quality-control for scientists

Is there any downtime after an infusion appointment
